InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
55%
T+90 mean return
+23.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Clements Ian, Chief Financial Officer. Director active across 1 company, notably Mirum Pharmaceuticals, Inc.. In total, 12 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €18k. History available since 10 May 2021. The latest transaction was disclosed on 10 November 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
325 shares@ US$17.0517.7% of flowCommon StockSEC:0001209191-22-056891:0
1,125 shares@ US$13.5660.0004% mcap21.7% of flowCommon StockSEC:0001209191-22-028719:0
10,000 shares0Common StockSEC:0001209191-22-002426
10,000 shares0Common StockSEC:0001209191-22-002426:0
700 shares@ US$14.400.0002% mcap13.4% of flowCommon StockSEC:0001209191-21-067068:0
Ideal exit: 21 Aug 2022 (T+270)
700 shares@ US$14.400.0002% mcap34.3% of flowCommon StockSEC:0001209191-21-067068
Ideal exit: 21 Aug 2022 (T+270)
458 shares@ US$13.5150.0001% mcap8.0% of flowCommon StockSEC:0001209191-21-064447:0
458 shares@ US$13.5150.0001% mcap20.4% of flowCommon StockSEC:0001209191-21-064447
9,375 shares0Common StockSEC:0001209191-21-058607:0
9,375 shares0Common StockSEC:0001209191-21-058607
981 shares@ US$14.6217.7% of flowCommon StockSEC:0001209191-21-032139
981 shares@ US$14.620.0003% mcap17.7% of flowCommon StockSEC:0001209191-21-032139:0
12 of 12 declarations
About Clements Ian
Ian Clements is the Chief Financial Officer at Mirum Pharmaceuticals, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the growth and financial stability of Mirum.
